Does tadalafil raise blood sugar is a common concern for men with diabetes considering this medication for erectile dysfunction. There is no established clinical evidence that tadalafil directly raises blood glucose levels. Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, does not appear in UK regulatory guidance or medical literature as causing hyperglycaemia. The MHRA and EMA do not list elevated blood glucose as a recognised adverse effect. This is reassuring for the many men with diabetes who may benefit from tadalafil, as erectile dysfunction affects approximately 50% of men with diabetes. Understanding the relationship between tadalafil and blood sugar helps ensure safe, effective treatment.

Does Tadalafil Raise Blood Sugar Levels?

There is no established clinical evidence that tadalafil directly raises blood sugar levels. Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor commonly prescribed for erectile dysfunction and benign prostatic hyperplasia, does not appear in current medical literature as a medication that causes hyperglycaemia or worsens glycaemic control in people with diabetes.

The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) do not list elevated blood glucose as a recognised adverse effect in the tadalafil Summary of Product Characteristics. Clinical trials and post-marketing surveillance data have not demonstrated a causal relationship between tadalafil use and increased blood sugar levels. This is reassuring for the many men with diabetes who may require tadalafil for erectile dysfunction, which affects approximately 50% of men with diabetes according to Diabetes UK.

However, it is important to understand the broader context. Erectile dysfunction itself is often an early indicator of cardiovascular disease and metabolic dysfunction, conditions closely linked with diabetes. If you notice changes in your blood sugar readings after starting tadalafil, this may reflect underlying health changes rather than a direct drug effect.

Patients with diabetes can generally use tadalafil, but should maintain regular blood sugar monitoring as part of their routine diabetes management. Important safety note: Tadalafil is contraindicated with nitrates and the medication riociguat, and should be used with caution alongside alpha-blockers and antihypertensives due to potential blood pressure effects. If you have concerns about any medication and your blood glucose control, discussing these with your GP or diabetes specialist nurse is always advisable.

Blood Sugar Monitoring While Taking Tadalafil

Maintaining consistent blood sugar monitoring remains essential for anyone with diabetes, regardless of whether they are taking tadalafil. The principles of diabetes management do not change when this medication is introduced. If you currently monitor your blood glucose levels at home, you should continue with your established routine as advised by your diabetes care team.

For most people with type 2 diabetes not using insulin or sulfonylureas, routine self-monitoring of blood glucose is generally not recommended unless specifically advised by your healthcare team, in line with NICE guidance (NG28). Those using insulin or experiencing unstable glucose control typically require more frequent testing. When starting any new medication, including tadalafil, it can be prudent to monitor slightly more frequently for the first few weeks to establish your individual response and ensure your diabetes control remains stable.

Key monitoring considerations include:

• Testing at consistent times (such as fasting readings before breakfast)

• Recording results in a diary or digital app to identify patterns

• Noting any symptoms of hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar)

• Checking blood glucose if you feel unwell or notice unusual symptoms

According to NHS and Diabetes UK guidance, target blood glucose levels for most adults with type 2 diabetes are 4-7 mmol/L before meals and under 8.5 mmol/L two hours after meals. Your individual targets may differ based on your circumstances, so follow the specific advice from your diabetes team. Remember that HbA1c remains the main measure of long-term diabetes control. If you notice persistent readings outside your target range after starting tadalafil, contact your GP or diabetes nurse for review, though remember that tadalafil itself is unlikely to be the cause.

When to Speak to Your GP About Tadalafil and Diabetes

You should contact your GP or diabetes care team if you experience any concerning changes in your health or diabetes control whilst taking tadalafil. Whilst the medication does not directly affect blood sugar, certain situations warrant professional medical advice to ensure your overall health and safety.

Seek medical advice if you notice:

• Persistent blood glucose readings outside your usual target range despite no changes to diet, exercise, or diabetes medications

• Symptoms of poorly controlled diabetes such as increased thirst, frequent urination, unexplained weight loss, or persistent fatigue

• Recurrent episodes of hypoglycaemia (blood sugar below 4 mmol/L)

• Any new or worsening symptoms after starting tadalafil

• Concerns about interactions between tadalafil and your other medications

It is particularly important to discuss tadalafil with your GP before starting treatment if you have:

• Cardiovascular disease or a history of heart attack or stroke

• Poorly controlled diabetes with recent HbA1c levels above target

• Diabetic complications such as retinopathy, neuropathy, or nephropathy

• Low blood pressure or take medications for hypertension, particularly alpha-blockers

Seek immediate medical attention if you experience:

• A painful erection lasting more than 4 hours (priapism)

• Sudden vision or hearing loss

Tadalafil is contraindicated with nitrates used for angina and the medication riociguat, causing dangerous drops in blood pressure. Your GP will review your complete medication list and medical history before prescribing. Never stop taking tadalafil or adjust your diabetes medications without professional guidance. If you experience chest pain whilst taking tadalafil, seek immediate medical attention by calling 999, do not take nitrates, and inform paramedics that you have taken tadalafil. For non-urgent concerns, book a routine appointment with your GP or contact your diabetes specialist nurse through your usual healthcare provider.

If you suspect tadalafil has caused any side effects, you can report these through the MHRA Yellow Card scheme.

How Tadalafil Works in the Body

Understanding tadalafil's mechanism of action helps explain why it does not directly affect blood sugar levels. Tadalafil belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. Its primary action occurs through a specific biochemical pathway that influences smooth muscle relaxation in blood vessels, particularly those supplying the penis and, in different dosing regimens, the lungs and prostate.

The mechanism works as follows: When sexual stimulation occurs, nerve endings release nitric oxide, which activates an enzyme called guanylate cyclase. This produces cyclic guanosine monophosphate (cGMP), a chemical messenger that relaxes smooth muscle in blood vessel walls, allowing increased blood flow to the penis and facilitating an erection. The enzyme PDE5 normally breaks down cGMP, ending the erection. Tadalafil inhibits PDE5, allowing cGMP levels to remain elevated for longer, thus supporting erectile function.

This mechanism is highly specific to the PDE5 enzyme and the vascular smooth muscle pathway. There is no established direct pharmacological effect of tadalafil on insulin secretion, glucose absorption in the intestines, or glucose metabolism in the liver—the primary mechanisms that regulate blood sugar levels.

Tadalafil is absorbed from the gastrointestinal tract and reaches peak blood concentrations at a median of approximately 2 hours (range 0.5-6 hours) after taking the medication. It has a notably long half-life of approximately 17.5 hours, which is why it can be effective for up to 36 hours—considerably longer than other PDE5 inhibitors. The medication is metabolised primarily in the liver by the cytochrome P450 enzyme CYP3A4 and excreted mainly in faeces. For people with diabetes, particularly those with diabetic complications affecting blood vessels and nerves, tadalafil can be an effective treatment option for erectile dysfunction, addressing the vascular component of this common complication without evidence of adversely affecting glycaemic control.

It's worth noting that tadalafil is used at a low daily dose (5 mg) for benign prostatic hyperplasia, while higher doses are used for pulmonary arterial hypertension (marketed as Adcirca).

Frequently Asked Questions